Description
BPC-157 + TB-500 Combined Research Matrix
This premium laboratory matrix pairs two distinct regenerative reference compounds into a single, uniform solution. By combining these structural agents in a single vessel, researchers can analyze the dual-action mechanisms and potential overlapping cellular signaling pathways of both compounds simultaneously without variance in cross-measuring.
Technical Specifications
-
Composition: Compound BPC (Body Protection Compound) + Compound TB (Thymosin Beta-4 fragment)
-
Total Active Mass: [Insert Total mg, e.g., 10 mg (5 mg + 5 mg)] per vial
-
Purity Profile: Greater than 99% pure active materials (HPLC and Mass Spectrometry verified)
-
Physical Form: Dry lyophilized (freeze-dried) powder
-
Packaging: Vacuum-sealed, temperature-controlled glass vial
-
Storage Requirements: Store at -20°C for long-term stability. Protect from prolonged exposure to light and moisture.
Primary Research Objectives
-
Angiogenesis and Tissue Remodeling: Investigating how the concurrent introduction of both compounds affects new blood vessel formation and structural cellular proliferation in vitro.
-
Extracellular Matrix (ECM) Synthesis: Evaluating the compounding effects on collagen deposition, actin regulation, and cellular migration speeds during tissue repair modeling.
-
Inflammatory Cascade Signaling: Mapping changes in localized cellular inflammation signaling pathways and structural upregulation within targeted in vivo and in vitro environments.
⚠️ STRICT REGULATORY & SAFETY NOTICE
For Laboratory Research Use Only. This material is synthesized and supplied exclusively for chemical analysis, in vitro diagnostic testing, and laboratory evaluation. It is explicitly not for human or animal consumption, injection, clinical trial, or therapeutic application. Handling is strictly restricted to qualified research professionals in an authorized laboratory environment.
